-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, G0xjDY6XOTngnxikDRB/Qi4hOQSh62Sr7Lemd+mVCDMr8vFG767S+u4fHtWQ4sCe pzbdNVwiWl+awCcA0o/VuQ== 0000905729-07-000285.txt : 20070712 0000905729-07-000285.hdr.sgml : 20070712 20070712141136 ACCESSION NUMBER: 0000905729-07-000285 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20070702 FILED AS OF DATE: 20070712 DATE AS OF CHANGE: 20070712 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INTERLEUKIN GENETICS INC CENTRAL INDEX KEY: 0001037649 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 943123681 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 135 BEAVER ST CITY: WATHAM STATE: MA ZIP: 02452 BUSINESS PHONE: 1-781-398-0700 MAIL ADDRESS: STREET 1: 135 BEAVER ST CITY: WATHAM STATE: MA ZIP: 02452 FORMER COMPANY: FORMER CONFORMED NAME: MEDICAL SCIENCE SYSTEMS INC DATE OF NAME CHANGE: 19971003 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WEAVER JAMES M CENTRAL INDEX KEY: 0001257134 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32715 FILM NUMBER: 07976131 BUSINESS ADDRESS: BUSINESS PHONE: 616 803-2203 MAIL ADDRESS: STREET 1: 4300 44TH ST SE CITY: GRAND RAPIDS STATE: MI ZIP: 49512 3 1 primary_doc.xml PRIMARY DOCUMENT X0202 3 2007-07-02 0 0001037649 INTERLEUKIN GENETICS INC (ILI) 0001257134 WEAVER JAMES M C/O 7575 FULTON STREET EAST ADA MI 49355 1 0 0 0 No Securities owned. 0 D /s/ Daniel C. Persinger, by power of attorney 2007-07-12 EX-24 2 weaverpoa.htm INTERLEUKIN/WEAVER POA FOR FORM 3 LIMITED POWER OF ATTORNEY

EXHIBIT 24

LIMITED POWER OF ATTORNEY

                    I appoint GORDON R. LEWIS and DANIEL C. PERSINGER, or any one or more of them, each with full power of substitution, my attorneys and agents to do any and all acts and things and to execute and file any and all instruments that such attorneys and agents, or any of them, may consider necessary or advisable to enable the undersigned (in his or her individual capacity or in a fiduciary or other capacity) to comply with the Securities Exchange Act of 1934, as amended (the "Act"), and any requirements of the Securities and Exchange Commission in respect thereof, in connection with the preparation, execution and filing of any report or statement of beneficial ownership or changes in beneficial ownership of securities of INTERLEUKIN GENETICS, INC. (the "Company") that I (in my individual capacity or in a fiduciary or other capacity) may be required to file pursuant to Sections 13 or 16 of the Act including, without limitati on, full power and authority to sign my name, in my individual capacity or in a fiduciary or other capacity, to any report, application or statement on Form ID, Forms 3, 4 or 5, Schedules 13D or 13G, or to any amendments or any successor form or forms adopted by the Securities and Exchange Commission ratify and confirm all that such attorneys and agents, or any of them do or cause to be done under this power.

                    I agree that the attorneys-in-fact named may rely entirely on information furnished orally or in writing by me to such attorneys-in-fact. I agree to indemnify and hold harmless the attorneys-in-fact against any losses, claims, damages or liabilities (or actions in respect thereof) that arise out of or are based upon any untrue statement or omission of necessary fact in the information provided by the undersigned to the attorneys-in-fact for purposes of executing, acknowledging, delivering or filing any such forms, or any amendments or any successor forms thereto, or any form or forms adopted by the Securities and Exchange Commission.

                    This authorization shall be in addition to all prior authorizations to act for the undersigned with respect to securities of the Company in these matters.



Date: July 10, 2007

 /s/ James M. Weaver
 

James M. Weaver




-----END PRIVACY-ENHANCED MESSAGE-----